For example, biomarker panels consisting of 3–5 top metabolites and proteins selected by the RF showed superior performance compared to the currently used single marker Prostate Specific Antigen in predicting the progression of prostate cancer at different stages27. This evidence concerns the gene KLK3 and prostate cancer.